Phase 2 Ovarian Cancer Trial, Recruiting NCT06842524 Sponsor: Shanghai Zhongshan Hospital Condition: Ovarian Cancer
Back to Ovarian Cancer

Phase 2 Ovarian Cancer Trial, Recruiting

NCT06842524
Recruiting Phase 2

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are a woman diagnosed with Polycystic Ovary Syndrome (PCOS), meaning you have irregular periods (cycles shorter than 21 days, longer than 35 days, or fewer than 8 periods per year) AND higher-than-normal male hormones or excess body hair.
  • Your Body Mass Index (BMI) is between 18.5 and 28 (a measure of weight relative to height that falls in the normal to slightly overweight range).
  • You have a negative pregnancy test at the time of joining.
  • You are not planning to become pregnant in the next 6 months.

Who may not be able to join:

  • You are currently taking birth control pills, hormonal implants, or hormone injections — though some types of oral hormonal treatments may allow participation after a waiting period of one to two months (confirm with trial site).
  • You have liver disease shown by abnormal liver blood test results or high bilirubin levels (a substance measured in the blood).
  • You have anemia (low red blood cell levels) or a low level of certain white blood cells that help fight infection.
  • You have kidney disease, shown by an above-normal level of creatinine (a waste product) in your blood.
  • You have another hormonal condition (such as Cushing's syndrome, an underactive thyroid, or certain adrenal gland disorders) that could cause symptoms similar to PCOS.
  • You have been diagnosed with Type 1 or Type 2 diabetes.
  • You have a known heart condition, such as heart failure, an irregular heartbeat, or coronary heart disease.
  • You have a history of any type of cancer.
  • You are currently taking certain medications that affect hormones or metabolism, including metformin or GLP-1 medications (like those used for weight loss or diabetes) — a two-month waiting period off these medications may be required (confirm with trial site).
  • You have had weight-loss (bariatric) surgery within the past 12 months.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
Phase 2: approximately ~30% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.
Phase success rates shown are historical industry-wide averages based on published data. They are not a prediction for this specific trial or your individual situation.

Contact this trial

Principal Investigator: Xi Dong, MD, Reproductive Medicine Center, Zhongshan Hospital, Fudan University

Phone: 86-021-64041990

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Phase 2
Registry
ClinicalTrials.gov
Start date
16 April 2025
Est. completion
30 September 2026

Where this trial is recruiting

🇨🇳 China

Primary endpoints

The occurrence of a regular menstrual cycle

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov